Litcius/Paper detail

Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studies

Bruce Cree, Ashish Pradhan, Jinglan Pei, Mitzi Williams

2021Multiple Sclerosis and Related Disorders17 citationsDOI

Topics & Concepts

OcrelizumabMedicineMultiple sclerosisInterferon beta-1aInternal medicineAfrican descentOperaGastroenterologySurgeryImmunologyInterferon betaSociologyRituximabLymphomaLiteratureAnthropologyArtMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersSystemic Lupus Erythematosus Research
Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studies | Litcius